| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $265.5M | — | +16.6% |
| Cost of Revenue | $166.0M | — | +20.3% |
| Gross Profit | $99.5M | — | +10.8% |
| R&D Expense | $33.3M | — | +17.6% |
| SG&A Expense | $36.1M | — | +10.0% |
| Operating Income | -$7.7M | — | -523.4% |
| Pre-tax Income | $1.0M | — | -90.4% |
| Income Tax | -$565K | — | -108.2% |
| Net Income | $1.6M | — | -57.8% |
| EPS (Basic) | $0.04 | — | -55.6% |
| EPS (Diluted) | $0.04 | — | -55.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $480.8M | +19.1% | +32.4% |
| Short-term Investments | $332.1M | -23.7% | -41.1% |
| Accounts Receivable | $192.4M | +5.9% | +8.8% |
| Inventory | $319.0M | +1.8% | +10.9% |
| Current Assets | $1.43B | +0.7% | -0.7% |
| Total Assets | $2.42B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.5M | — | -140.6% |
| Capital Expenditures | $16.3M | — | -34.3% |
| Investing Cash Flow | $95.2M | — | +134.7% |
| Financing Cash Flow | -$11.7M | — | -106.6% |
| Free Cash Flow | -$21.8M | — | -91.5% |
| +4.5% |
| Current Liabilities | $247.2M | +5.6% | +25.4% |
| Total Liabilities | $305.8M | +3.3% | +19.1% |
| Stockholders' Equity | $2.12B | -0.6% | +2.7% |